AI literature review tools can help regulatory and scientific teams search, screen, organize, and summarize growing volumes of information. Their greatest value lies in narrow, repetitive tasks such as developing search terms, removing duplicates, prioritizing abstracts, comparing documents, and extracting predefined data.
However, AI cannot yet reliably replace qualified reviewers. It may miss important sources, misinterpret regulatory or scientific context, rely on low-quality evidence, fabricate citations, overlook contradictory findings, or produce confident conclusions from incomplete searches. Proprietary tools may also create transparency, confidentiality, copyright, and data-governance concerns.
The most defensible approach is to use AI as an adjunct—not as the final decision-maker. Organizations need documented search methods, authoritative source verification, traceable citations, risk-based human oversight, and clear rules governing what information may be uploaded. AI can improve efficiency, but regulatory and scientific conclusions must remain accurate, reproducible, and owned by qualified experts.
Artificial intelligence is increasingly being used to search, screen, summarize, and organize large volumes of regulatory and scientific information. In regulatory intelligence, AI tools may help teams monitor changing requirements, identify relevant guidance, compare documents, and prepare preliminary summaries. In literature reviews, they may assist with search-term development, citation screening, data extraction, evidence mapping, and drafting plain-language summaries.
The potential is significant. Regulatory and scientific teams face expanding volumes of publications, guidance documents, safety communications, standards, enforcement actions, and jurisdiction-specific requirements. AI may reduce the time spent on repetitive work and help specialists find relevant information more efficiently.
However, regulatory intelligence and literature review are not simply information-retrieval exercises. Both require judgment about source authority, relevance, scientific quality, jurisdiction, timing, applicability, and context.
The central question is therefore not whether AI can assist with these activities. It is whether organizations can use AI without weakening the completeness, transparency, traceability, and expert judgment on which defensible regulatory decisions depend.
Regulatory intelligence involves the systematic collection, assessment, and communication of information that may affect a product, submission, development program, quality system, or market-access strategy.
The required level of control depends on the type and purpose of the review. Exploratory landscape searches, scoping reviews, rapid reviews, and systematic reviews have different methodological requirements. An AI-assisted search should not be described as systematic or comprehensive unless the underlying methodology supports that description.
AI-supported tools may be used to:
These functions can be valuable because regulatory information is often distributed across multiple agencies, databases, webpages, PDFs, notices, standards, and historical documents. Requirements may also differ according to product classification, indication, jurisdiction, development stage, or intended use.
AI can help reduce the manual burden involved in finding and organizing this material. It may also make it easier for teams to detect developments across large information sets that would otherwise require substantial time to review.
But finding information is not the same as determining what that information means for a specific product or organization.
AI tools are also being introduced throughout the evidence-review process.
Depending on the tool and intended use, they may assist with:
Evidence is currently most established for semi-automated, human-supervised tasks such as title and abstract screening. Performance is more variable and context-dependent for comprehensive searching, data extraction, risk-of-bias assessment, interpretation, and final synthesis. This distinction matters. An AI tool may reduce the number of citations that a reviewer must examine without being reliable enough to determine independently which evidence should be included, excluded, or relied upon.
When selected for a defined context of use, evaluated against representative tasks, and appropriately supervised, AI may provide several practical advantages.
Faster processing of large information volumes
AI systems can process and categorize documents more quickly than a person reviewing each item individually. This may be especially useful for initial screening, document comparison, deduplication, extraction of predefined fields, and prioritization of potentially relevant materials.
One recent overview noted that AI-supported tools may reduce the repetitive workload associated with screening and coding. Reducing this burden may also lessen the effects of reviewer fatigue during long and cognitively demanding review processes.
Earlier identification of relevant developments
In regulatory intelligence, AI-assisted monitoring may help organizations identify new consultations, safety communications, guidance updates, policy changes, or enforcement trends sooner.
The value is not necessarily that the AI determines the organization’s response. Rather, it may help direct qualified personnel toward developments requiring closer attention.
More structured information management
AI may help classify documents by jurisdiction, topic, product category, development phase, or regulatory function. It can also assist with extracting recurring elements into structured tables or internal databases.
For organizations managing substantial regulatory or scientific information, this may improve discoverability and reduce the time spent repeatedly locating the same source material.
More efficient evidence screening
Specialized review tools may prioritize records that appear most likely to meet predefined inclusion criteria. Some tools can learn from human screening decisions and reorder the remaining records accordingly.
This can accelerate screening while keeping the review team accountable for the screening strategy, thresholds, audit checks, and final included evidence. Where automation is used to eliminate records or replace a screener, its use, version, and validation should be reported. In one review of available tools, all seven selected systems continued to leave critical decisions with researchers rather than fully automating the review.
Reduced inconsistency in repetitive tasks
Human reviewers can apply criteria inconsistently, particularly when processing thousands of records over extended periods. Properly configured tools may apply the same prioritization or extraction rules repeatedly.
This does not remove bias, because the model, training data, search strategy, and human instructions may introduce their own biases. It may, however, reduce certain forms of inconsistency associated with fatigue or repetitive manual processing.
The strengths of AI are generally greatest where the task is narrow, structured, repetitive, and easy to verify.
The risks increase when AI is expected to determine:
These activities require more than retrieving or reorganizing words. They require contextual and domain-specific judgment.
A literature search can appear productive while still missing important studies. Similarly, an AI-generated regulatory landscape can appear comprehensive while omitting a relevant jurisdiction, historical policy, device-specific requirement, agency interpretation, or recently updated source.
Traditional systematic searching is designed around reproducibility, database selection, documented search strings, inclusion criteria, and methods for assessing completeness. General-purpose AI systems may not disclose exactly what they searched, what they could access, how results were ranked, or why certain documents were excluded.
An evaluation comparing an AI research tool with traditional evidence-synthesis searching found that the tool did not search with sufficient sensitivity to replace conventional methods. Its higher precision could still make it useful for preliminary searching or as an adjunct, but not as a comprehensive substitute.
In regulatory intelligence, the same problem may arise when a concise and persuasive report creates the impression that the relevant landscape has been fully assessed.
A polished answer is not evidence of a complete search.
AI tools may retrieve or summarize material without reliably distinguishing among:
An editorial examining AI in scholarly searches raised concerns that AI may fail to recognize predatory journals, sham research, retracted publications, and poor-quality evidence. In a 2025 evaluation, GPT-4o-mini was given the titles and abstracts of 217 retracted or otherwise concerning articles and asked 30 times to assess each article’s quality. None of the 6,510 outputs identified the retractions or relevant errors, and 190 articles received relatively high scores.
Regulatory intelligence presents an equivalent source-hierarchy problem. An agency regulation, official guidance document, conference presentation, inspection observation, and third-party blog post may all contain useful information, but they do not carry the same authority.
AI-generated summaries may flatten these distinctions unless the system and its users are specifically designed to preserve them.
Regulatory documents frequently contain qualifications, exceptions, cross-references, implementation dates, transition periods, definitions, and jurisdiction-specific terminology.
A requirement may apply only to:
AI may correctly extract an individual sentence while incorrectly representing its scope.
Literature reviews face a similar challenge. A study result may depend on population characteristics, sample size, intervention duration, endpoints, study design, comparator, statistical assumptions, or risk of bias. Summarizing the conclusion without these limitations can materially alter its meaning.
AI may fabricate citations, article details, quotations, regulatory requirements, document titles, agency positions, or links. It may also combine accurate fragments from different sources into a conclusion that no single authoritative source supports.
This risk is especially difficult to detect because the output may be fluent, detailed, and professionally written.
The concern is not limited to entirely invented references. Partially incorrect citations can be equally disruptive. An article may exist, but the authors, title, journal, date, DOI, or findings may be misstated. A regulatory document may also be genuine while the AI inaccurately summarizes its status or applicability.
For this reason, every source that influences a regulated decision must remain independently retrievable and verifiable.
A 2026 preprint evaluating LLM-based scientific agents across eight domains and more than 25,000 runs reported that evidence was ignored in 68% of reasoning traces and that refutation-driven belief revision occurred in 26%. The study did not specifically test regulatory-intelligence or literature-review workflows, but it illustrates a relevant risk when agentic systems are asked to interpret evolving evidence. The reference material supplied for this article describes research in which AI agents frequently ignored experimental evidence, made unsupported claims, and struggled to revise conclusions when results contradicted their initial position.
This limitation is directly relevant to regulatory intelligence. New evidence may require an analyst to reconsider:
An AI system that preserves its initial framing despite conflicting evidence may produce an internally coherent but unreliable analysis.
Many AI tools are proprietary systems. Users may not know:
A review of AI tools for systematic research synthesis found that several lacked sufficiently detailed documentation about their underlying algorithms. The authors emphasized that transparency is necessary for users to understand limitations, evaluate potential bias, and maintain scientific rigor.
This is particularly important in regulated industries, where organizations may need to reconstruct why information was selected, how it was assessed, and how a conclusion was reached.
AI-assisted review may involve uploading complete articles, internal regulatory assessments, unpublished study reports, confidential correspondence, product information, or licensed database content.
Doing so may create concerns involving:
Uploading licensed publications to a third-party AI platform may breach publisher or database licence terms. Acceptability depends on the applicable licence, the tool’s data-handling and retention terms, and whether it operates within an approved controlled environment. Organizations should therefore assess not only the accuracy of an AI tool but also what information users are permitted to provide to it.
AI is often adopted on the assumption that it will accelerate review. That may be true for some narrow tasks.
However, time savings can disappear when specialists must:
The relevant comparison is not between AI output and no output. It is between the complete controlled workflow with AI and the complete controlled workflow without it.
Where an AI-assisted process creates extensive verification work, the total workflow may not be faster than a well-designed human-led process.
Current evidence-synthesis guidance supports using AI to assist qualified reviewers within a controlled and transparently reported methodology. It is that the technology is most defensible when it supports qualified reviewers within a controlled methodology.
AI may be appropriate for:
AI should not independently determine:
The distinction is between assisting the process and owning the conclusion.
Not every use of AI creates the same level of risk.
| Use case | Potential role for AI | Principal control |
| Preliminary horizon scanning | Identify potentially relevant developments | Confirm against official sources |
| Search-term development | Suggest keywords, synonyms, and concepts | Have a qualified reviewer approve the strategy |
| Document monitoring | Flag new or changed materials | Verify completeness and document status |
| Title and abstract screening | Prioritize records | Retain human inclusion and exclusion decisions |
| Data extraction | Populate predefined fields | Compare entries with the source text |
| Regulatory document comparison | Identify possible changes | Conduct expert legal and regulatory review |
| Evidence summary | Draft a structured overview | Verify each statement and citation |
| Quality or risk-of-bias assessment | Provide preliminary prompts or flags | Require independent expert assessment |
| Regulatory interpretation | Organize relevant considerations | Keep conclusions with qualified regulatory personnel |
| Final strategy or submission position | Limited drafting support | Require documented human ownership and approval |
The greater the potential effect on patient safety, product quality, market authorization, claims, clinical decisions, or compliance obligations, the stronger the oversight should be.
Organizations using AI for regulatory intelligence or literature reviews should consider controls covering the full process rather than focusing only on the final output.
This may include:
An approved use case
The intended task, user group, data inputs, expected outputs, and prohibited uses should be defined before the tool becomes embedded in routine work.
An authoritative source hierarchy
Binding legislation and regulations, official agency decisions and databases, final and draft guidance, recognized standards, and peer-reviewed publications should be identified separately and weighted according to their authority, status, jurisdiction, and effective date.
A documented search method
Users should record the databases and websites searched, complete search strings or keywords, dates searched, date limits, and inclusion and exclusion criteria. Where AI or automation is used, records should also identify the tool, model and version where available, access date, relevant configuration or prompts, screening rules, and the tool’s role in the workflow.
Source-level traceability
Every significant statement should be connected to an accessible source. Users should be able to retrieve the original passage and confirm that it supports the conclusion.
Human review proportionate to risk
Qualified personnel should verify outputs before they affect submissions, safety assessments, clinical documents, quality records, claims, or regulatory strategy.
Testing and performance monitoring
Organizations should test the tool against representative tasks and known source sets. Performance should be reassessed when the model, vendor, workflow, or intended use changes.
Documentation of limitations
Records should describe what the tool could not search, which sources were unavailable, where human judgment was applied, and what uncertainties remain.
Data-use controls
Policies should identify what information may be uploaded, where it may be processed, whether it is retained, and whether vendor terms are acceptable.
Disclosure where appropriate
Where AI meaningfully supports a review, report, manuscript, or regulatory analysis, the organization should consider whether the tool and its role need to be documented or disclosed.
What this means for regulated organizations
AI can make regulatory intelligence and evidence review more efficient, but it does not reduce the organization’s responsibility for the final work product.
If an incomplete search, inaccurate summary, unsupported citation, or incorrect interpretation enters a regulatory submission or controlled record, the fact that an AI tool produced it does not transfer accountability to the tool provider.
Organizations remain responsible for demonstrating that:
The objective should not be to reproduce a traditional review more quickly at any cost. It should be to design a better controlled process in which automation is applied only where its performance can be understood, reviewed, and defended.
Organizations introducing AI into regulatory intelligence and literature-review workflows should be asking:
These questions help distinguish controlled AI assistance from unstructured reliance on a system that may produce convincing outputs without a defensible evidentiary process.
At dicentra, we understand that regulatory intelligence and scientific literature review are not simply administrative research functions. They can influence product development, market authorization, clinical strategy, safety assessments, labeling, claims, quality systems, and post-market obligations.
As organizations introduce AI into these workflows, we can support them by:
Our role is to help organizations use AI where it provides genuine value without allowing speed, automation, or polished presentation to substitute for scientific rigor and regulatory judgment.
AI may help find, organize, and process information. The final assessment must still be accurate, transparent, traceable, and defensible.
Contact dicentra for support with regulatory intelligence, scientific literature reviews, AI governance, and controlled implementation of AI in regulated workflows.